Anzeige
Mehr »
Donnerstag, 12.02.2026 - Börsentäglich über 12.000 News
Top-Ergebnisse: 1,75 g/t Gold über 30,4 Meter + massives Tagebau-Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
25 Leser
Artikel bewerten:
(0)

Global Cell Expansion (Stem Cell Research, Regenerative Medicine, Clinical Diagnostics) Market - Forecast to 2019

DUBLIN, Nov. 12, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Cell Expansion Market by Product , Cell Type, Application, End User - Forecast to 2019" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

The global cell expansion market involves various products that help in mass production specific cells from a tissue or a sample. This market is driven by several factors which include increasing cancer research, technological advancements, high prevalence of chronic diseases, and growth in government investments. The relatively untapped Asian market and increasing number of stem cell research have opened an array of opportunities for growth of the cell expansion market. However, high cost of instruments and ethical concerns are expected to restrain the growth of this market.

The global cell expansion market is expected to reach $14.8 billion by 2019 from $6.0 billion in 2014, growing at a CAGR of 19.7% from 2014 to 2019. The cell expansion market is segmented on the basis of product, cell type, application, end-user, and geography.

On the basis of product, the cell expansion market is segmented into consumables and instruments. In 2014, the consumables segment is expected to account for the largest share of the global cell expansion market, by product. The high share can be attributed to the extensive requirement of media in cell expansion process. The consumables market is further divided into reagents, media and serum, and disposables. The instrument market is segmented into automated cell expansion systems, bioreactors and supporting equipment. Supporting equipment include centrifuges, flow cytometers, filtration systems, incubators, microscopes, laminar air flow cabinets and others. The others segment includes strainers, water baths, vortex mixers, pipettes, and cell counters. The bioreactors segment is further categorized into micro carrier bioreactor and perfusion or hollow fiber bioreactors.

The cell expansion market by cell type is bifurcated into human cells and animal cells. The human cell market is further sub segmented into stem cells and differentiated cells. The stem cell expansion market is poised to witness the highest growth in the cell expansion market, by cell type, owing to the increasing government funding of stem cell research and investments by companies to boost the research in cancer.

Prominent players in the cell expansion market are Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.),Corning Incorporation (U.S.), GE Healthcare (U.K.),Merck Millipore (U.S.), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Sigma-Aldrich Corporation (U.S.), Terumo BCT (U.S.),and Thermo Fisher Scientific Inc. (U.S.).

Key Topics Covered:


1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Trends

7 Cell Expansion Market, By Product

8 Cell Expansion Market, By Cell Type

9 Cell Expansion Market, By Application

10 Cell Expansion Market, By End User

11 Cell Expansion Market, By Geography

12 Competitive Landscape

13 Company Profiles

14 Appendix

Companies Mentioned:

  • Beckman Coulter (Subsidiary of Danaher Corporation)
  • Becton Dickinson and Company
  • Corning Incorporated
  • Ge Healthcare (A Fully Owned Subsidiary of General Electric Company)
  • Merck Millipore (A Segment of Merck Kgaa)
  • Miltenyi Biotec
  • Sigma-Aldrich Corporation
  • Stemcell Technologies
  • Terumo BCT (A Subsidiary of Terumo Corporation)
  • Thermo Fisher Scientific, Inc.

For more information visit http://www.researchandmarkets.com/research/3v3kdj/cell_expansion

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

© 2014 PR Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.